Company Data

Clearside Biomedical Inc.

Ticker
CLSD
Current Price
$1.03 -1.9%
Market Cap
$78.1M
Price Target
Refer to Report
Volume
467.1K
52wk Range
$0.801 - $2.12
Advanced Market Data

Overview

Clearside Biomedical Inc is a United States based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy